drugset / Trial / NCT01765374

Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis

NCT01765374

Phase 4 Completed 30 enrolled University Hospital, Rouen
NaSingle-groupOpen-labelTreatment

Summary

To detect by sonography relapse of disease activity prior to clinical symptoms in RA patients treated by rituximab.

Timeline

Start
2011-02
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Rituximab Monoclonal antibody

Indications